Tavapadon, a drug made by AbbVie to treat Parkinson’s disease, met phase 3 TEMPO-1 trial goals treated early Parkinson's disease and improved motor skills, the company reported on Thursday.

"It's hard to say or predict the future as to whether or not Brett Favre or other folks we maybe know in our community would ...

Researchers at UAB found blows to the head, like football players regularly experience, play a “significant” role in a person ...

Pitching for Parkinson's in Grand Chute provides insight and support to those living with disease Max Matus, 18, says the ...

When Phyllis Higgins’ father Johnnie Franklin continued to arrive for his doctor’s appointments in mismatched clothes and ...

Former Vikings QB Tommy Kramer said it was Hall of Fame quarterback Brett Favre’s revelation of his Parkinson’s diagnosis ...

A tremor that won’t stop, slow movements, rigid muscles they’re the classic signs of Parkinson’s disease that alert doctors ...

As if on cue, on Sept. 24, 54-year-old National Football League Hall of Famer Brett Favre revealed during unrelated testimony ...

This summary highlights major health news, including Bavarian Nordic's UNICEF agreement for mpox vaccines, Pfizer's ...

Gulf War illness (GWI), a chronic fatigue condition affecting veterans, is linked to genetic variants in mitochondrial DNA.

Deep brain stimulation is an effective treatment for motor symptoms in patients with movement disorders such as Parkinson's ...

Dr. Danielle Larson, Movement Disorders Specialist at Northwestern Medicine, joins Jon Hansen (in for Lisa Dent) to discuss ...